The Street’s Key Stock Analysts Research Reports


Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers.

Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of stocks analysts have singled out to look at carefully Tuesday, as follows:

Ambarella Inc. (NASDAQ:AMBA) Morgan Stanley reiterated it as Overweight and raised the target price to 60 from 52. Cowen reiterated it as Outperform and raised the target price to 68 from 54.

Dollar General Corp. (NYSE:DG) Morgan Stanley reiterated its Overweight rating and raised the target price to 155 from 142, and Barclays reiterated its Overweight rating and raised its target to 180 from 141. Piper Jaffray reiterated its Overweight rating and raised its target to 170 from 137.

Smartsheet Inc. (NYSE:SMAR) was reiterated as Outperform with a 62 target price at Wedbush.

Ulta Beauty Inc. (NASDAQ:ULTA) UBS maintained its Buy rating but cut the target to 300 from 365, Cowen maintained its Outperform rating but cut its target to 313 from 375. Wells Fargo downgraded it to Market Perform from Outperform.

Zymeworks Inc. (NYSE:ZYME) was started with a Buy rating and assigned a 45 target price at Stifel. The stock has a 52-wk trading range of 10.72 to 27.19 and a consensus target price of 24.88.

Have a terrific week

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :